Want to see MET full AI Analyst Report?
Top Page
Metlife
(NYSE:MET)
Select Model
Select Model
Rating:79Outperform
Price Target:
$112.00
â–²(18.11% Upside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by strong financial quality (notably robust and improving cash generation) and a positive earnings-call outlook highlighted by reiterated targets and significant capital returns. Technicals are also supportive with a clear uptrend and positive momentum. Valuation is acceptable but not especially inexpensive, and near-term investment spread/variable investment income softness is the main risk tempering the score.
Positive Factors
Strong Cash Generation
Sustained operating and free cash flow provides financial resilience, supports ongoing investment and shareholder distributions, and improves MetLife’s ability to absorb underwriting or investment volatility without relying heavily on external capital.
Negative Factors
Investment Spread Pressure
MetLife’s earnings depend materially on investment spreads and alternative-asset returns. Persistent weakness in private equity and variable investment income could reduce retirement-solutions profitability and make earnings less predictable.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Cash Generation
Sustained operating and free cash flow provides financial resilience, supports ongoing investment and shareholder distributions, and improves MetLife’s ability to absorb underwriting or investment volatility without relying heavily on external capital.
Read all positive factors
Metlife Key Performance Indicators (KPIs)
Any
Assets Under Management
Totals the investments MetLife manages for itself and clients, indicating the scale of its investment operations and potential fee or investment income. Larger AUM can boost earnings but also increases sensitivity to market and interest-rate moves that affect asset values and capital requirements.
Totals the investments MetLife manages for itself and clients, indicating the scale of its investment operations and potential fee or investment income. Larger AUM can boost earnings but also increases sensitivity to market and interest-rate moves that affect asset values and capital requirements.
Data provided by:
The Fly
The FlyMetlife (MET) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$60.44B
Dividend Yield2.48%
Average Volume (3M)3.63M
Price to Earnings (P/E)17.8
Beta (1Y)0.94
Revenue Growth8.96%
EPS Growth-11.62%
CountryUS
Employees46,000
SectorFinancial
Sector Strength70
IndustryInsurance - Life
Share Statistics
EPS (TTM)5.25
Shares Outstanding635,476,900
10 Day Avg. Volume3,540,794
30 Day Avg. Volume3,631,730
Financial Highlights & Ratios
PEG Ratio-0.83
Price to Book (P/B)1.85
Price to Sales (P/S)0.68
P/FCF Ratio2.90
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$105.36Price Target Upside11.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)9.96
Revenue Forecast (FY)$80.13B
Metlife Business Overview & Revenue Model
Company Description
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary div...
How the Company Makes Money
MetLife primarily makes money by underwriting insurance and providing benefit and retirement-related products while investing the premiums it collects. Key revenue and earnings drivers include: (1) Premiums and risk-based underwriting margins: For...
Metlife Earnings Call Summary
Earnings Call Date:Aug 05, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 04, 2026
Earnings Call Sentiment Positive
The call conveyed strong, broad-based operational performance and capital returns: adjusted earnings and EPS grew meaningfully, ROE reached the top of the target range, multiple regions delivered double-digit growth (notably Group, Asia and Latin America), AUM grew to $748 billion, and the company announced a new $3 billion buyback while maintaining a healthy holding-company cash buffer. Offsetting risks include below-guidance total spreads driven by weak private equity returns and lower-than-run-rate variable investment income, a lighter and lumpy PRT market in H1, some normalization expected in favorable Group mortality experience, and a short-term earnings impact from mark-to-market items and the PineBridge expense footprint. Overall, positive operational momentum and capital flexibility outweigh the near-term investment and market headwinds.Positive Updates
Strong Adjusted Earnings and EPS Growth
Adjusted earnings of approximately $1.6 billion ($2.43 per share); adjusted earnings rose 15% year-over-year and adjusted EPS increased 20% year-over-year.
Negative Updates
Normalization Risk in Group Mortality Favorability
Group Life mortality ratio improved to 79% driven in part by about 2 points of prior period development and lower-than-expected severity; management expects some normalization heading into the rest of the year.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Adjusted Earnings and EPS Growth
Adjusted earnings of approximately $1.6 billion ($2.43 per share); adjusted earnings rose 15% year-over-year and adjusted EPS increased 20% year-over-year.
Read all positive updates
Company Guidance
MetLife reiterated its 2026 targets and near‑term expectations, highlighting an annual adjusted ROE target of 15–17% (Q2 at 17%), a 2026 direct expense‑ratio target of 12.1% (Q2 = 12.1% and they expect to beat the full‑year target), MIM adjusted‑earnings guidance of $240–$280M (likely toward the low end) with total AUM of $748B, and RIS spread guidance (core spread ~100 bps; total spread Q2 = 97 bps vs. prior 100–120 bps guidance). Other metrics/guidance included retained‑liability growth of 3–5% (Q2 = +3% Y/Y), holding‑company cash buffer $3–$4B (Q2 cash $3.4B), a new $3B share‑repurchase authorization (Q2 repurchases ≈ $700M; YTD returns >$2.4B and ~$1.1B returned in Q2), estimated U.S. statutory adjusted capital (NAIC) ≈ $16.4B, Japan ESR expected at the top end of a 170–190% range, a Q2 pretax variable investment income run‑rate of $231M (PE avg return 0.8%, real estate/other 1.1% with stronger PE returns expected in Q3), and an effective tax‑rate outlook of ~24–26% (Q2 was 23%).Metlife Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
74
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.65B | 77.08B | 69.94B | 67.71B | 67.97B | 63.37B |
| Gross Profit | 20.10B | 28.02B | 19.00B | 17.29B | 18.94B | 16.84B |
| EBITDA | 5.96B | 6.47B | 7.37B | 3.92B | 7.97B | 10.13B |
| Net Income | 3.63B | 3.38B | 4.43B | 1.58B | 5.28B | 6.86B |
Balance Sheet | ||||||
| Total Assets | 748.13B | 745.17B | 677.46B | 687.58B | 663.07B | 759.71B |
| Cash, Cash Equivalents and Short-Term Investments | 338.80B | 125.34B | 108.78B | 316.83B | 313.32B | 367.50B |
| Total Debt | 20.29B | 20.18B | 18.71B | 18.83B | 17.98B | 17.43B |
| Total Liabilities | 720.33B | 716.25B | 649.75B | 657.33B | 632.95B | 691.96B |
| Stockholders Equity | 27.32B | 28.40B | 27.45B | 30.02B | 29.88B | 67.48B |
Cash Flow | ||||||
| Free Cash Flow | 16.57B | 18.11B | 15.12B | 14.26B | 11.37B | 12.83B |
| Operating Cash Flow | 16.57B | 18.11B | 15.12B | 14.26B | 11.37B | 12.83B |
| Investing Cash Flow | -23.63B | -15.61B | -11.49B | -10.25B | -2.62B | -11.19B |
| Financing Cash Flow | 5.27B | 163.00M | -3.13B | -2.94B | -9.95B | -1.38B |
Metlife Technical Analysis
Neutral
94.83
Price Trends
91.83
Positive
84.79
Positive
79.94
Positive
Market Momentum
1.11
Positive
44.64
Neutral
6.97
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MET, the sentiment is Neutral. The current price of 94.83 is below the 20-day moving average (MA) of 96.38, above the 50-day MA of 91.83, and above the 200-day MA of 79.94, indicating a neutral trend. The MACD of 1.11 indicates Positive momentum. The RSI at 44.64 is Neutral, neither overbought nor oversold. The STOCH value of 6.97 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MET.
Metlife Risk Analysis
Metlife disclosed 46 risk factors in its most recent earnings report. Metlife reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Metlife Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $60.44B | 17.80 | 12.95% | 2.42% | 8.96% | -11.62% | |
74 Outperform | $13.18B | 11.13 | 20.28% | 0.69% | 5.24% | 21.35% | |
72 Outperform | $42.17B | 10.82 | 12.00% | 4.58% | 9.38% | 144.26% | |
71 Outperform | $58.41B | 12.46 | 16.42% | 1.89% | 13.57% | 110.75% | |
70 Outperform | $8.32B | 3.50 | 21.99% | 4.35% | 12.32% | 97.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $13.87B | 20.27 | 6.43% | 2.19% | 3.34% | -48.74% |
* Financial Sector Average
MET
Metlife
93.46
16.42
21.31%
AFL
AFLAC
116.17
10.20
9.62%
LNC
Lincoln National
41.98
3.16
8.15%
PRU
Prudential Financial
120.59
16.23
15.56%
GL
Globe Life
170.49
31.99
23.10%
UNM
Unum Group
86.95
19.25
28.43%
Metlife Corporate Events
Business Operations and StrategyDividends
MetLife Declares Q3 2026 Dividends on Preferred Stock
Positive
Aug 17, 2026
On August 17, 2026, MetLife, Inc. declared third quarter 2026 dividends on multiple series of its non-cumulative preferred stock, including floating rate Series A and fixed-to-floating Series D, as well as Series E and Series F represented by depo...
Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
MetLife posts strong Q2 results and boosts buybacks
Positive
Aug 5, 2026
On August 5, 2026, MetLife reported second-quarter 2026 results showing continued momentum under its New Frontier strategy, with net income rising 1% year-on-year to $705 million, or $1.09 per share. Adjusted earnings climbed 15% to $1.6 billion a...
Financial Disclosures
MetLife Issues Cautious Update on Variable Investment Income
Neutral
Jun 29, 2026
MetLife disclosed preliminary variable investment income for the quarter ended June 30, 2026, estimating pre-tax income of $220 million to $270 million, against full-year 2026 guidance of about $1.6 billion. The figure reflects contributions from ...
Executive/Board ChangesShareholder Meetings
MetLife Shareholders Back Board, Auditor and Executive Pay
Positive
Jun 22, 2026
At its annual meeting of common shareholders held on June 16, 2026, MetLife, Inc. shareholders elected eleven directors to serve terms expiring at the 2027 annual meeting, signaling broad support for the current board’s composition and gover...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.